Using ziconotide for treating severe chronic pain not related to cancer
Official title: Ziconotide for Non-cancer Pain by Intrathecal Administration
Run by ESTEVE Pharmaceuticals SAS · NCT06541184 · Data updated 2026-11-12
This study is trying to see if ziconotide can safely help people with severe chronic pain that isn't related to cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 85 (estimated) |
| Sponsor | ESTEVE Pharmaceuticals SAS Industry-sponsored |
| Drugs / interventions | chemotherapy |
| Locations | 14 sites (Aubagne and 13 other locations) |
| Status | Recruiting |
| Started | October 30, 2024 |
| Main results expected | October 30, 2029 |
| Study ends | October 30, 2029 |
| Registry record updated | February 27, 2025 |
| Trial ID | NCT06541184 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older suffering from chronic non-cancer pain that requires interventional treatment.
✕Probably not a fit
Patients who have contraindications to intrathecal therapy or ziconotide, or those unable to participate in data collection, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry aims to gather data on patients suffering from chronic non-cancer pain who are treated with ziconotide-based intrathecal analgesia. The study seeks to document the effectiveness and safety of ziconotide in this population, as its use has primarily been associated with cancer pain management. By collecting information from both current users of ziconotide and new candidates for treatment, the registry hopes to provide valuable insights that could guide future clinical decisions. The study addresses the gap in knowledge regarding the use of ziconotide for non-cancer pain, which is often overlooked due to a lack of comprehensive data.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for patients with severe chronic pain who have not responded to standard therapies.
How similar studies have gone: While ziconotide has been primarily studied in cancer pain, this approach for non-cancer pain is less documented, indicating a novel exploration in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years, 2. Chronic non-cancer pain requiring interventional techniques, and eligible to ziconotide-containing intrathecal therapy, 3. Having received information on and not opposed to data collection, Inclusion criteria specific for the retrospective cohort: Currently treated by ziconotide-based ITA according to SmPC whatever the duration of treatment Inclusion criteria specific for the prospective cohort: Naïve of ITA and candidate to ziconotide-based ITA or already treated by IT route without ziconotide, scheduled for addition of ziconotide in the pump Exclusion Criteria: 1. Contraindication to intrathecal therapy or to ziconotide 2. Any condition that may jeopardize appropriate follow-up of the treatment 3. Patient under guardianship or deprived of liberty by a judicial or administrative decision or unable to express opposition to data collection.
Where it's running
-
Clinique de la Casamance
Aubagne, France Recruiting -
Hospices Civils de Lyon
Bron, France Recruiting -
CHD Vendée
La Roche-sur-Yon, France Recruiting -
CH Laon
Laon, France Recruiting -
CHU Lille
Lille, France Recruiting -
Clinique Mutualiste de la Porte de l'Orient
Lorient, France Recruiting
Show 8 more locations
-
Centre Léon Bérard
Lyon, France Recruiting -
CH Yves Le foll
Saint-Brieuc, France Recruiting -
CHU St Etienne
Saint-Etienne, France Recruiting -
Polyclinique du Parc
Caen, France Not yet recruiting -
Hopital Saint Joseph
Paris, France Not yet recruiting -
CHU Poitiers
Poitiers, France Not yet recruiting -
CHU Reims
Reims, France Not yet recruiting -
IUCT Toulouse
Toulouse, France Not yet recruiting
Study contacts
- Study coordinator: CHEVALLIER Arthur
- Email: achevallier@esteve.com
- Phone: +33 (0)7 84 15 86 75
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Therapeutic yoga and interoceptive awareness in adolescents with chronic pain
This will test whether an occupational therapy plan that includes therapeutic yoga helps adolescents (ages 11–21) with chronic pain improve body awareness and day-to-day function.
-
Butyrate and Taurine for Chronic Postoperative Pain in Adults after Cardiac Surgery
This study tests whether taking taurine and butyrate daily can reduce long-lasting pain after cardiac surgery in adults.
-
VMD-3866 topical gel for chemotherapy-induced nerve pain
This trial will test whether a non-opioid topical gel called VMD-3866 can reduce pain in adults with chemotherapy-induced peripheral neuropathy.
-
Home-based ear (taVNS) stimulation for IBS pain
This trial will test whether a home-based ear vagus nerve stimulation device, used twice daily for six weeks, helps reduce pain and symptoms in 18–29-year-olds with IBS compared with a look‑alike sham device.
-
Effects of prescription opioids on brain structure and cognition in older adults with chronic pain
This study is testing how taking prescription opioids affects the brain and thinking skills in older adults with chronic pain.
-
Pain Reprocessing Therapy for persistent knee pain after knee replacement
This trial will test whether Pain Reprocessing Therapy (PRT) delivered by video can reduce persistent knee pain in adults who still have meaningful pain three months after knee replacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.